Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what proportion of the NHS’s stock of Philips CPAP machines for home treatment of sleep apnoea are (a) with patients as of 24 May 2022 and (b) affected by the worldwide field safety notice in place relating to certain Philips machines.

The most recent data available from Philips shows that as of 23 May 2022, 7% of the Philips continuous positive airway pressure (CPAP) machines for the home treatment of sleep apnoea registered as being in use by National Health Service patients have been replaced with new devices as part of the Philips ongoing remediation programme, with 93% of affected devices still in use. The Philips remediation programme aims to replace or repair all affected Philips CPAP machines affected by the field safety notice and registered as being in use within the next 12 months, with the proportions projected to be 50% replacement and 50% repair.

NHS England and NHS Improvement’s clinical respiratory networks will assist with the coordination of the repair and replace programme at regional level with Philips and local providers. The decision to apply filters is subject to clinical review with each patient. Data on the number of filters provided for use with affected Philips CPAP devices is not collected centrally. New Philips CPAP machines for the home treatment of sleep apnoea will be unavailable for purchase in the United Kingdom until Philips has completed the remediation programme. CPAP machines from alternative suppliers have been procured and are being supplied to NHS sleep services.